BC Innovations | Nov 30, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: November 2017

New Therapeutic Targets and Biomarkers: November 2017 Select top therapeutic targets and biomarkers covered by BioCentury or added to the BCIQ database during November 2017. Therapeutic targets are defined as any protein, gene or other...
BC Week In Review | Nov 17, 2017
Company News

Excision licenses new CRISPR IP from Berkeley

Excision BioTherapeutics Inc. (Philadelphia, Pa.) obtained exclusive licenses to IP from University of California Berkeley covering new CRISPR-based gene editing technologies. The licenses include the use of CRISPR systems using CRISPR-associated protein X (Cas X),...
Items per page:
1 - 2 of 2